Duke University Medical Center Dept. of DUMC (4) — Durham, North Carolina

Duke University Medical Center Dept. of DUMC (4) is a clinical research site located in Durham, North Carolina, United States 27710.

Crixeo Health Trust Score: 62/100 (FAIR). This profile has not yet been claimed by the site owner.

Duke University Medical Center Dept. of DUMC (4) has participated in 3 clinical trials.

Therapeutic areas: Relapsed and Bortezomib Refractory Multiple Myeloma, Refractory Multiple Myeloma, Multiple Myeloma in Relapse.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 62/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Duke University Medical Center Dept. of DUMC (4)?

Duke University Medical Center Dept. of DUMC (4) has a Crixeo Trust Score of 62/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Duke University Medical Center Dept. of DUMC (4) conducted?

Duke University Medical Center Dept. of DUMC (4) has 3 clinical trials on record. Their work covers Relapsed and Bortezomib Refractory Multiple Myeloma, Refractory Multiple Myeloma, Multiple Myeloma in Relapse.

Is Duke University Medical Center Dept. of DUMC (4) accredited by Crixeo Health?

Duke University Medical Center Dept. of DUMC (4) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Duke University Medical Center Dept. of DUMC (4)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.